Optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology

Environmental Health Perspectives

Volumn 123, Issue 7, 2015, Pages A166-A168

  Calafat, Antonia M ^a   Longnecker, Matthew P ^b   Koch, Holger M ^c   Swan, Shanna H ^d   Hauser, Russ ^e   Goldman, Lynn R ^f   Lanphear, Bruce P ^g   Rudel, Ruthann A ^h   Engel, Stephanie M ⁱ   Teitelbaum, Susan L ^d   Whyatt, Robin M ^j   Wolff, Mary S ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g BC CHILDREN S HOSPITAL   (Canada)

^h Silent Spring Institute   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j Department of Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; ENVIRONMENTAL CHEMICAL; PHTHALIC ACID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; POLLUTANT;

ARTICLE; BLOOD; DRUG EXPOSURE; HUMAN; MEDICAL DEVICE; PERSISTENT ORGANIC POLLUTANT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREGNANCY; PRIORITY JOURNAL; RELIABILITY; URINE; ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; PHARMACOKINETICS; POLLUTANT; PROCEDURES;

BIOMARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS;

EID: 84936127037     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1510041     Document Type: Article

References (48)

1. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. 2008. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect 116(4):467–473; doi:10.1289/ehp.10749.
2. Alcock RE, Halsall CJ, Harris CA, Johnston AE, Lead WA, Sanders G, et al. 1994. Contamination of environmental samples prepared for PCB analysis. Environ Sci Technol 28(11):1838–1842; doi:10.1021/es00060a013.
3. Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Holler JS, Needham LL, et al. 1992. Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry. Anal Chem 64(9):1021–1029.
4. Baird DD, Saldana TM, Nepomnaschy PA, Hoppin JA, Longnecker M P, Weinberg CR, et al. 2010. Within-person variability in urinary phthalate metabolite concentrations: measurements from specimens after long-term frozen storage. J Expo Sci Environ Epidemiol 20(2):169–175; doi:10.1038/jes.2009.17.
5. Barr DB, Wilder LC, Caudill S P, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113(2):192–200; doi:10.1289/ehp.7337.
6. Bolann BJ, Rahil-Khazen R, Henriksen H, Isrenn R, Ulvik RJ. 2007. Evaluation of methods for trace-element determination with emphasis on their usability in the clinical routine laboratory. Scand J Clin Lab Invest 67(4):353–366; doi:10.1080/00365510601095281.
7. Braun JM, Kalkbrenner AE, Calafat AM, Bernert JT, Ye X, Silva MJ, et al. 2011. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119(1):131–137; doi:10.1289/ehp.1002366.
8. Calafat AM, Needham LL. 2009. What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data? Environ Health Perspect 117(10):1481–1485; doi:10.1289/ehp.0901108.
9. Cantonwine DE, Cordero JF, Rivera-Gonzalez LO, Anzalota Del Toro LV, Ferguson KK, Mukherjee B, et al. 2014. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ Int 62:1–11; doi:10.1016/j.envint.2013.09.014.
10. Engel LS, Buckley J P, Yang G, Liao LM, Satagopan J, Calafat AM, et al. 2014. Predictors and variability of repeat measurements of urinary phenols and parabens in a cohort of Shanghai women and men. Environ Health Perspect 122(7):733–740; doi:10.1289/ehp.1306830.
11. Engel SM, Wolff MS. 2013. Causal inference considerations for endocrine disruptor research in children’s health. Annu Rev Public Health 34:139–158; doi:10.1146/annurev-publ-health-031811-124556.
12. Fankhauser-Noti A, Grob K. 2007. Blank problems in trace analysis of diethylhexyl and dibutyl phthalate: investigation of the sources, tips and tricks. Anal Chim Acta 582(2):353–360; doi:10.1016/j.aca.2006.09.012.
13. Fisher M, Arbuckle TE, Mallick R, LeBlanc A, Hauser R, Feeley M, et al. 2015. Bisphenol A and phthalate metabolite urinary concentrations: daily and across pregnancy variability. J Expo Sci Environ Epidemiol 25(3):231–239; doi:10.1038/jes.2014.65.
14. Frederiksen H, Kranich SK, Jorgensen N, Taboureau O, Petersen JH, Andersson AM. 2013. Temporal variability in urinary phthalate metabolite excretion based on spot, morning, and 24-h urine samples: considerations for epidemiological studies. Environ Sci Technol 47(2):958–967; doi:10.1021/es303640b.
15. Guidry VT, Longnecker M P, Aase H, Eggesbo M, Zeiner P, Reichborn-Kjennerud T, et al. 2015. Measurement of total and free urinary phenol and paraben concentrations over the course of pregnancy: assessing reliability and contamination of specimens in the Norwegian Mother and Child Cohort study. Environ Health Perspect 123(7):705–711; doi:10.1289/ehp.1408325.
16. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. 2004. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect 112(17):1734–1740; doi:10.1289/ehp.7212.
17. Hines E P, Calafat AM, Silva MJ, Mendola P, Fenton SE. 2009. Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ Health Perspect 117(1):86–92; doi:10.1289/ehp.11610.
18. Irvin EA, Calafat AM, Silva MJ, Aguilar-Villalobos M, Needham LL, Hall DB, et al. 2010. An estimate of phthalate exposure among pregnant women living in Trujillo, Peru. Chemosphere 80(11):1301–1307; doi:10.1016/j.chemosphere.2010.06.048.
19. Jaeger RJ, Rubin RJ. 1970. Plasticizers from plastic devices extraction, metabolism, and accumulation by biological systems. Science 170(3956):460–462; PMID:5460077.
20. Jusko TA, Shaw PA, Snijder CA, Pierik FH, Koch HM, Hauser R, et al. 2014. Reproducibility of urinary bisphenol A concentrations measured during pregnancy in the Generation R Study. J Expo Sci Environ Epidemiol 24(5):532–536; doi:10.1038/jes.2014.23.
21. Koch HM, Aylward LL, Hays SM, Smolders R, Moos RK, Cocker J, et al. 2014. Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: personal care product ingredients. Toxicol Lett 231(2):261–269; doi:10.1016/j.tox-let.2014.06.023.
22. Koch HM, Calafat AM. 2009. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 364(1526):2063–2078; doi:10.1098/rstb.2008.0208.
23. Koch HM, Kolossa-Gehring M, Schroter-Kermani C, Angerer J, Bruning T. 2012. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol 22(6):610–616; doi:10.1038/jes.2012.39.
24. Larson DF, Mayall B, Anderson RM. 1977. Hemolysis due to chemical contamination of clinical perfusion apparatus. Ann Thorac Surg 23(4):374–375.
25. Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Main KM, Skakkebæk NE, et al. 2013. Temporal variability in urinary excretion of bisphenol A and seven other phenols in spot, morning, and 24-h urine samples. Environ Res 126:164–170; doi:10.1016/j.envres.2013.07.001.
26. Longnecker M P, Harbak K, Kissling GE, Hoppin JA, Eggesbo M, Jusko TA, et al. 2013. The concentration of bisphenol A in urine is affected by specimen collection, a preservative, and handling. Environ Res 126:211–214; doi:10.1016/j.envres.2013.07.002.
27. Mahalingaiah S, Meeker JD, Pearson KR, Calafat AM, Ye X, Petrozza J, et al. 2008. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 116(2):173–178; doi:10.1289/ehp.10605.
28. Marcus M, Christensen KY, Manatunga A, Rudra CB, Brock JW, Small CM. 2010. Variability of phthalate monoester levels in daily frst-morning urine from adult women: a pilot study. Rev Environ Health 25(4):359–368; doi:10.1515/REVEH.2010.25.4.359.
29. Marega M, Grob K, Moret S, Conte L. 2013. Phthalate analysis by gas chromatography-mass spectrometry: blank problems related to the syringe needle. J Chromatogr A 1273:105–110; doi:10.1016/j.chroma.2012.11.076.
30. Markham DA, Waechter JM, Wimber M, Rao N, Connolly P, Chuang JC, et al. 2010. Development of a method for the determination of bisphenol A at trace concentrations in human blood and urine and elucidation of factors infuencing method accuracy and sensitivity. J Anal Toxicol 34(6):293–303; doi:10.1093/jat/34.6.293.
31. Meeker JD, Calafat AM, Hauser R. 2012. Urinary phthalate metabolites and their biotransfor-mation products: predictors and temporal variability among men and women. J Expo Sci Environ Epidemiol 22(4):376–385; doi:10.1038/jes.2012.7.
32. Meeker JD, Cantonwine DE, Rivera-Gonzalez LO, Ferguson KK, Mukherjee B, Calafat AM, et al. 2013. Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol 47(7):3439–3447; doi:10.1021/es400510g.
33. Nepomnaschy PA, Baird DD, Weinberg CR, Hoppin JA, Longnecker M P, Wilcox AJ. 2009. Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res 109(6):734–737; doi:10.1016/j.envres.2009.04.004.
34. National Research Council. 2008. Phthalates and Cumulative Risk Assessment: The Tasks Ahead. Washington, DC:National Academies Press.
35. Philippat C, Wolff MS, Calafat AM, Ye X, Bausell R, Meadows M, et al. 2013. Prenatal exposure to environmental phenols: concentrations in amniotic fuid and variability in urinary concentrations during pregnancy. Environ Health Perspect 121(10):1225–1231; doi:10.1289/ehp.1206335.
36. Pirkle JL, Needham LL, Sexton K. 1995. Improving exposure assessment by monitoring human tissues for toxic chemicals. J Expo Anal Environ Epidemiol 5(3):405–424.
37. Preau JL Jr, Wong LY, Silva MJ, Needham LL, Calafat AM. 2010. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect 118(12):1748–1754; doi:10.1289/ehp.1002231.
38. Quirós-Alcalá L, Eskenazi B, Bradman A, Ye X, Calafat AM, Harley K. 2013. Determinants of urinary bisphenol A concentrations in Mexican/Mexican-American pregnant women. Environ Int 59:152–160; doi:10.1016/j.envint.2013.05.016.
39. Smith KW, Braun JM, Williams PL, Ehrlich S, Correia KF, Calafat AM, et al. 2012. Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect 120(11):1538–1543; doi:10.1289/ehp.1104614.
40. Teeguarden J, Hanson-Drury S, Fisher JW, Doerge DR. 2013. Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population? Food Chem Toxicol 62:949–963; doi:10.1016/j.fct.2013.08.001.
41. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, Reidy JA, et al. 2008. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res 106(2):257–269; doi:10.1016/j.envres.2007.09.010.
42. Townsend MK, Franke AA, Li X, Hu FB, Eliassen AH. 2013. Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses’ Health Studies: a prospective cohort study. Environ Health 12(1):80; doi:10.1186/1476-069X-12-80.
43. Valvi D, Monfort N, Ventura R, Casas M, Casas L, Sunyer J, et al. 2015. Variability and predictors of urinary phthalate metabolites in Spanish pregnant women. Int J Hyg Environ Health 218(2):220–231; doi:10.1016/j.ijheh.2014.11.003.
44. Vandenberg LN, Gerona RR, Kannan K, Taylor JA, van Breemen RB, Dickenson CA, et al. 2014. A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ Health 13(1):25; doi:10.1186/1476-069X-13-25.
45. Vandentorren S, Zeman F, Morin L, Sarter H, Bidondo ML, Oleko A, et al. 2011. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ Res 111(6):761–764; doi:10.1016/j.envres.2011.05.018.
46. Yan X, Calafat A, Lashley S, Smulian J, Ananth C, Barr D, et al. 2009. Phthalates biomarker identification and exposure estimates in a population of pregnant women. Hum Ecol Risk Assess 15(3):565–578; doi:10.1080/10807030902892554.
47. Ye X, Wong LY, Bishop AM, Calafat AM. 2011. Variability of urinary concentrations of bisphenol A in spot samples, frst morning voids, and 24-hour collections. Environ Health Perspect 119(7):983–988; doi:10.1289/ehp.1002701.
48. Ye X, Zhou X, Hennings R, Kramer J, Calafat AM. 2013. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitor-ing analysis: an elusive laboratory challenge. Environ Health Perspect 121(3):283–286; doi:10.1289/ehp.1206093.